You can see from this quarter's financials, synergies have been identified and actions have begun to realize benefits, focusing on out-of-pocket spending and prioritizing investments to match future growth plans. In-house organizational structures have been implemented, and working toward reaching stea...
6:28pChewy is entering ‘beast mode,’ with more than 50% upside ahead, says analyst 6:15pNvidia’s stock rallies as AI chip trade reloads for fresh run higher 6:05pUlta Beauty rallies on new CEO pick and sales outlook that suggests ‘competitive pressures have peaked’ ...
周四,美银证券分析师Craig Bijou将Globus Medical(NYSE:GMED)的股票评级从减持上调至中性,并将目标价从80美元上调至97美元。 此次上调是因为Globus Medical成功整合了NuVasive,整合效果比最初预期的更好,降低了未来运营效率低下的风险。市场对这一整合反应积极,InvestingPro数据显示,过去一年该股回报率高达60.75%,目前...